https://european-biotechnology.net/wp-content/uploads/2025/01/Arctic_Therapeutics-e1737542077825-1030x484-1.png4841030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-22 10:37:442025-01-22 10:37:44Arctic Therapeutics ASA kicks off with €26.5m Series A round
https://european-biotechnology.net/wp-content/uploads/2025/01/von-der-Leyen-EB-e1737376382539-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-20 12:33:432025-01-20 12:33:43EuropaBio calling for EU Biotech Act
https://european-biotechnology.net/wp-content/uploads/2025/01/inflarx_antiko__rper-web.webp540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-16 14:36:222025-01-16 14:36:22InflaRx secures European Commission approval for ARDS drug
https://european-biotechnology.net/wp-content/uploads/2025/01/gr3_lrg-1030x730-1.jpg7301030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-13 08:42:232025-01-13 08:42:23First in vivo CAR gene therapy trial in Europe approved
https://european-biotechnology.net/wp-content/uploads/2025/01/synapse-Image-by-Pete-Linforth-from-Pixabay.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-01-10 09:56:352025-01-10 09:56:35Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders
